Stockreport

Millendo Therapeutics' livoletide flunks study; shares crater 69% premarket [Seeking Alpha]

Millendo Therapeutics, Inc. - Common Stock  (MLND) 
Last millendo therapeutics, inc. - common stock earnings: 11/13 08:30 am Check Earnings Report
PDF Thinly traded nano cap Millendo Therapeutics (NASDAQ:MLND69%unsuccessful resultsPhase 2b clinical trialPrader-Willi syndromeLivoletideThe company has decided to terminat [Read more]